For the second year running, some 37 organizations have launched a week-long mini campaign to raise awareness and promote action against falsified and substandard medicines. This year’s annual Fight the Fakes week aims to mobilize the public and international global health community to speak up more assertively about the growing threat of fake or substandard […] Continue reading ->
[Drugs for Neglected Diseases Initiative] Geneva, Switzerland (29 November 2019) – The Indian pharmaceutical company Cipla has announced their commitment to price the ground-breaking new product Quadrimune, a “4‑in‑1” treatment for young children with HIV, at below a dollar a day. Quadrimune is currently under review by the US Food and Drug Administration (FDA) for use in children […] Continue reading ->
African leaders, scientists, and activists are mobilizing to address the scientific, political, and social challenges inherent to ending the HIV epidemic. That was the key message as the 20th International Conference on AIDS and STIs in Africa (ICASA) kicked off on Monday in Kigali, Rwanda under the theme, “AIDS-free Africa: Innovation, Community and Political Leadership.” […] Continue reading ->
WHO and its partners have evacuated Ebola response workers in the Biakato Mines Area of the Democratic Republic of Congo following two deadly attacks on Wednesday night that left 4 Congolese staff dead, and 6 staff wounded – including a WHO staff member. The scale back of the Ebola response raises the possibility of a […] Continue reading ->
The World Health Organization has issued new HIV testing recommendations to help countries expand treatment coverage and reach the estimated 8.1 million people living with HIV who have not yet been diagnosed. The WHO guidelines were released on Wednesday ahead of World AIDS Day on December 1 and the International Conference on AIDS and Sexually […] Continue reading ->
The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading ->
Unitaid will expand its work in malaria to include chemoprevention for infants in the first year of life and pilot a new “agility” mechanism to support global health innovation in 2020, following approval granted by Unitaid’s Executive Board on November 20 to 21. The Board’s approval will allow Unitaid to launch a call for proposals […] Continue reading ->
Over the last 20 years, MMV has worked with over 400 partner organizations in 55 countries; involving tens of thousands of individuals. At a recent anniversary event held in Geneva, some of those key players told their stories – bringing to life the contributions made by so many more people over the past 20 years. […] Continue reading ->
Global leaders pledged US$2.6 billion to the global fight to eradicate polio at the Reaching the Last Mile (RLM) forum in Abu Dhabi on Tuesday, just one day ahead of World Children’s Day. The commitment fulfills part of the first phase of funding requested by the Global Polio Eradication Initiative to finance their 2019 – […] Continue reading ->
Efforts to eliminate river blindness, a debilitating parasitic disease that causes vision loss in 1.15 million people, may be threatened by another infection known as African eye worm, according to a modelling study published in Clinical Infectious Diseases. While the World Health Organization has set a target to eliminate river blindness in most African countries […] Continue reading ->